Literature DB >> 9395380

Presence of human immunodeficiency virus (HIV) type 1 subtype A infection in a New York community with high HIV prevalence: a sentinel site for monitoring HIV genetic diversity in North America. Centers for Disease Control and Prevention-Bronx Lebanon HIV Serosurvey Team.

K L Irwin1, C P Pau, D Lupo, D Pienazek, C C Luo, N Olivo, M Rayfield, D J Hu, J T Weber, R A Respess, R Janssen, P Minor, J Ernst.   

Abstract

To determine whether US residents are infected with subtypes of human immunodeficiency virus (HIV) type 1 other than subtype B (Western), the predominant North American subtype with a unique GPGR genetic sequence in the V3 loop, viruses from 22 HIV-infected adults were serotyped and subtyped. Twenty patients had subtype B (Western), of whom 15 had serotype B (Western), 3 had serotype A/C, 1 had serotype B (Thai), and 1 had a nontypeable serotype. Two had subtype A, both serotype A/C. Both subtype A-infected patients, only 1 of whom had been outside the United States, reported sex with persons traveling abroad, suggesting possible acquisition in the United States. Because US residents are infected with non-subtype B (Western) strains, US surveillance for HIV-1 diversity is needed to elucidate subtype-specific transmission patterns and pathogenesis and to guide evaluation and development of HIV diagnostic tests and vaccines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395380     DOI: 10.1086/517343

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Efficacy of a preventive intervention for youths living with HIV.

Authors:  M J Rotheram-Borus; M B Lee; D A Murphy; D Futterman; N Duan; J M Birnbaum; M Lightfoot
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

2.  The Changing Epidemic of HIV.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

3.  Integrating laboratory and epidemiological techniques for population-based surveillance of HIV strains and drug resistance in Canada.

Authors:  G C Jayaraman; C P Archibald; L Lior; D Sutherland
Journal:  Can J Infect Dis       Date:  2000-03

4.  Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.

Authors:  S Emery; S Bodrug; B A Richardson; C Giachetti; M A Bott; D Panteleeff; L L Jagodzinski; N L Michael; R Nduati; J Bwayo; J K Kreiss; J Overbaugh
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

5.  Performance characteristics of human immunodeficiency virus type 1 (HIV-1) genotyping systems in sequence-based analysis of subtypes other than HIV-1 subtype B.

Authors:  Linda L Jagodzinski; John D Cooley; Mark Weber; Nelson L Michael
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

6.  Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda.

Authors:  M Mracna; G Becker-Pergola; J Dileanis; L A Guay; S Cunningham; J B Jackson; S H Eshleman
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  Determination of human immunodeficiency virus type 1 subtypes by a rapid method useful for the routine diagnostic laboratory.

Authors:  H H Kessler; D Deuretzbacher; E Stelzl; E Daghofer; B I Santner; E Marth
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

8.  Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population.

Authors:  M J Gonzales; R N Machekano; R W Shafer
Journal:  J Infect Dis       Date:  2001-09-10       Impact factor: 5.226

9.  Prevention for substance-using HIV-positive young people: telephone and in-person delivery.

Authors:  Mary Jane Rotheram-Borus; Dallas Swendeman; W Scott Comulada; Robert E Weiss; Martha Lee; Marguerita Lightfoot
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10-01       Impact factor: 3.731

10.  U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains.

Authors:  Kenneth E Robbins; Philippe Lemey; Oliver G Pybus; Harold W Jaffe; Ae S Youngpairoj; Teresa M Brown; Marco Salemi; Anne-Mieke Vandamme; Marcia L Kalish
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.